Antigen-specific immunity is mediated by humoral antibody and receptor-bearing T lymphocytes. Although antibody molecules have been characterized in detail, the antigen-specific receptor on T lymphocytes has only recently been identified by monoclonal antibodies, and the primary structure is still not known. This proposal takes advantage of a recently isolated cDNA clone that appears to encode one chain of the T cell antigen receptor. The first set of experiments are aimed at determining the primary structure of the receptor by nucleic acid sequencing. Receptor genes will be cloned and sequenced from T cell hybridomas specific for species variants of cytochrome c. The goal will be to characterize the delineation of variable, joining, and constant regions, the presence (or absence) of framework and hypervariable regions, and the amino acid residues important in determining antigen specificity, Ia specificity or both. The second set of experiments focuses on the expression patterns of this and other cross-hybridizing receptor genes in different T cell subsets. Cytotoxic and suppressor cells will be examined for genomic rearrangements (on genomic Southern blots), and mRNA expression (on Northern blots), and the expressed genes from these cells will be cloned and sequenced. Analysis of the data will focus on comparisons between sequences of functionally different T cells. The third set of experiments will focus on cell surface receptor expression relying on antibodies made to synthetic peptide homologues. Experiments will be designed to determine the levels of receptor expression by different cell types and at different stages in T cell differentiation. A long term goal of studying the structure of the T cell receptor will be to determine structure-function relationships by directed mutagenesis and DNA-mediated gene transfer. The proposed experiments lay the groundwork for such future endeavors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021372-02
Application #
3131426
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Mingueneau, Michael; Krishnaswamy, Smita; Spitzer, Matthew H et al. (2014) Single-cell mass cytometry of TCR signaling: amplification of small initial differences results in low ERK activation in NOD mice. Proc Natl Acad Sci U S A 111:16466-71
Hedrick, Stephen M (2012) Positive selection in the thymus: an enigma wrapped in a mystery. J Immunol 188:2043-5
Chang, Chiung-Fang; D'Souza, Warren N; Ch'en, Irene L et al. (2012) Polar opposites: Erk direction of CD4 T cell subsets. J Immunol 189:721-31
Gu, Luo; Ruff, Laura E; Qin, Zhengtao et al. (2012) Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody. Adv Mater 24:3981-7
Soto, Paula C; Stein, Lance L; Hurtado-Ziola, Nancy et al. (2010) Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol 184:4185-95
Hedrick, Stephen M (2009) Immune system: not so superior. Science 325:1623-4
McGargill, Maureen A; Ch'en, Irene L; Katayama, Carol D et al. (2009) Cutting edge: Extracellular signal-related kinase is not required for negative selection of developing T cells. J Immunol 183:4838-42
Fan, Heng-Yu; Liu, Zhilin; Shimada, Masayuki et al. (2009) MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 324:938-41
D'Souza, Warren N; Chang, Chiung-Fang; Fischer, April M et al. (2008) The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol 181:7617-29
McGargill, Maureen A; Sharp, Leslie L; Bui, Jack D et al. (2005) Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling. J Immunol 175:656-64

Showing the most recent 10 out of 44 publications